BioHealth News Archive
Seeking Pediatric Device Innovators; Contest Opens for $250K and Accelerator Support | HealthLeaders Media
Competition for startups aims to increase the pace of development and commercialization of critically needed pediatric medical devices. In the world of innovation, devices…
Read MoreChesapeake Digital Health Exchange aims to spur regional startup growth – Technical.ly Baltimore
A new initiative spearheaded by Johns Hopkins is setting out to organize and grow the digital health community in the region, with an aim…
Read MoreTEDCO’s Maryland Innovation Initiative Infuses $2.63M in New Round of Projects
COLUMBIA, Md., Jan. 8, 2020 /PRNewswire/ -- TEDCO, Maryland's economic engine for technology companies, announced its recent round of funding for select projects through the…
Read MoreCIT GAP Funds Invests in Jeeva to Decentralize and Improve Clinical Trial Operations
The Center for Innovative Technology (CIT) today announced that CIT GAP Funds has invested in Herndon, Va.-based Jeeva Informatics Solutions Inc. (Jeeva), a precision…
Read MoreNexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team · BioBuzz
NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM) nanotechnology platform, announced that industry veterans Han Myint,…
Read MoreNexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer · BioBuzz
NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM) nanotechnology platform, announced that industry veteran John Trainer,…
Read MoreLumaCyte Awarded Frost & Sullivan 2019 Global Single-Cell Analysis New Product Innovation Award for Its Novel Laser Force Cytology™ Technology
SANTA CLARA, Calif., Jan. 7, 2020 /PRNewswire/ -- Based on its recent analysis of the global single-cell analysis market, Frost & Sullivan recognizes LumaCyte, LLC…
Read MoreNexImmune Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer
GAITHERSBURG, Md., Jan. 09, 2020 (GLOBE NEWSWIRE) -- NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM)…
Read MoreLaboratory Space Available
Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® REIT, is the first and longest-tenured owner, operator, and developer uniquely focused on collaborative life…
Read MoreUMB, JHU Collaborate to Advance Drug Discovery – University of Maryland, Baltimore
The University of Maryland School of Pharmacy welcomed nearly 200 researchers from across the University of Maryland, Baltimore (UMB) and Johns Hopkins University (JHU)…
Read MoreGlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater China – GlycoMimetics, Inc.
ROCKVILLE, Md. & FOSTER CITY, Calif. & HANGZHOU, China--(BUSINESS WIRE)--Jan. 6, 2020-- GlycoMimetics, Inc. (NASDAQ: GLYC), a leader in the field of applied glycotechnology…
Read MoreBiotech, life sciences incubator opens in Manhattan | Real Estate Weekly
The largest biotechnology incubator of its kind in New York City has opened at 180 Varick Street in Hudson Square. BioLabs @ NYULangone is…
Read More(New Year Special) Investors vulnerable to risky biotech business – Korea Biomedical Review
President Moon Jae-in announced in May that the government would designate the biohealth industry as one of the three new sectors for future growth,…
Read MoreNew Theory For Cancer Immunotherapy – University of Maryland, Baltimore
Scientists from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) this week proposed a new theory, based on…
Read MoreTEDCO, NIST give four companies funding – Maryland Daily Record
The Maryland Technology Development Corp. and the National Institute of Standards and Technology awarded four companies a total of $448,000 to develop NIST-licensed technologies…
Read More